A personalized and safe approach is key, and any provider who skips these steps isn't prioritizing your health
There have now been many studies and analyses that suggest that the use of GLP-1 drugs goes beyond just weight loss and diabetes, with potential benefits ranging from helping mental illness and substance abuse to kidney disease, heart disease and even osteoarthritis, some experts say
[PMID: 32082707] PubMed record related to this compound for laboratory literature review
SAHPRA reported deficiencies including: Inadequate sterile manufacturing conditions Insufficient equipment for aseptic preparation Lack of appropriate air filtration and environmental controls Increased risk of contamination Contaminated injectable products may lead to serious infections and other complications
The only FDA-approved treatments (disulfiram, naltrexone, and acamprosate) have been modestly successful in treating AUD (e.g., naltrexone reduces relapse rates by 5%) (for a detailed review and meta-analysis 1,2 ), but still are severely under-prescribed